Evidence map›Paper›PMID 40029521›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2025

CRISPR/Cas9 Methods for Identification and Validation of Genes Regulating BCR-Mediated Antigen Uptake.

Melibea Berzosa, Adam Nathan McShane, Pratiti Nanda, Manon Williams, Dessislava Malinova

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Melibea BerzosaWellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, UK.
Adam Nathan McShaneWellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, UK.
Pratiti NandaWellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, UK.
Manon WilliamsWellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, UK.
Dessislava MalinovaWellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, UK. d.malinova@qub.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genome-wide CRISPR screens are a powerful tool to interrogate and identify gene function in a wide variety of applications and cell types. CRISPR-Cas9 technology using pooled CRISPR single guide RNA (sgRNA) libraries enables genetic editing in bulk in a large population of cells of interest. After selection of gene-edited cells, phenotyping effects can be evaluated by quantifying abundance (over- or under-representation) of individual sgRNAs using DNA sequencing. In addition to cell survival, these assays can be applied to investigations of drug sensitivity, as well as almost any cellular process with a clear phenotypic read out, for example, receptor internalization, migration, autophagy, and differentiation.Here, taking as an example the identification of molecular components governing B-cell antigen uptake through the B-cell receptor, we describe whole-genome, small-scale, and in vivo validation methods to identify and validate genes regulating BCR-mediated antigen uptake.

Indexed as

AntigensCRISPR-Cas SystemsReceptors, Antigen, B-CellAnimalsB-LymphocytesGene EditingHumansMiceRNA, Guide, CRISPR-Cas SystemsAntigensReceptors, Antigen, B-CellRNA, Guide, CRISPR-Cas SystemsAntigen uptakeB-cell receptorCRISPR-Cas9EndocytosisFlow cytometryGenome-wide screeningRamos B-cell

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.